| Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the … T Vos, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1211-1259, 2017 | 11264* | 2017 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 7877 | 2016 |
| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 6964 | 2020 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … S Abdalla, F Abd-Allah, MI Abdel Aziz The Lancet, 2015 | 5470 | 2015 |
| Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 3328* | 2015 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 VL Feigin, BA Stark, CO Johnson, GA Roth, C Bisignano, GG Abady, ... The Lancet Neurology 20 (10), 795-820, 2021 | 2917 | 2021 |
| Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage CS Anderson, E Heeley, Y Huang, J Wang, C Stapf, C Delcourt, R Lindley, ... New England Journal of Medicine 368 (25), 2355-2365, 2013 | 1653 | 2013 |
| Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 VL Feigin, AA Abajobir, KH Abate, F Abd-Allah, AM Abdulle, SF Abera, ... The Lancet Neurology 16 (11), 877-897, 2017 | 1526 | 2017 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 950 | 2018 |
| Rivaroxaban for stroke prevention after embolic stroke of undetermined source RG Hart, M Sharma, H Mundl, SE Kasner, SI Bangdiwala, SD Berkowitz, ... New England Journal of Medicine 378 (23), 2191-2201, 2018 | 931 | 2018 |
| Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of … H Wang, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1084-1150, 2017 | 873 | 2017 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990 … GBD 2013 Risk Factors Collaborators Lancet (London, England) 386 (10010), 2287, 2015 | 758 | 2015 |
| Stroke epidemiology, prevention, and management strategies at a regional level: Latin America and the Caribbean PM Lavados, AJM Hennis, JG Fernandes, MT Medina, B Legetic, ... The Lancet Neurology 6 (4), 362-372, 2007 | 531* | 2007 |
| Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke CS Anderson, T Robinson, RI Lindley, H Arima, PM Lavados, TH Lee, ... New England Journal of Medicine 374 (24), 2313-2323, 2016 | 446 | 2016 |
| Incidence, 30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: a 2-year community-based prospective study (PISCIS project) PM Lavados, C Sacks, L Prina, A Escobar, C Tossi, F Araya, W Feuerhake, ... The Lancet 365 (9478), 2206-2215, 2005 | 382 | 2005 |
| Prevention of stroke: a global perspective JD Pandian, SL Gall, MP Kate, GS Silva, RO Akinyemi, BI Ovbiagele, ... The Lancet 392 (10154), 1269-1278, 2018 | 352 | 2018 |
| Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial SMD Mees, A Algra, WP Vandertop, F van Kooten, HAJM Kuijsten, ... The Lancet 380 (9836), 44-49, 2012 | 301 | 2012 |
| Primary stroke prevention worldwide: translating evidence into action MO Owolabi, AG Thrift, A Mahal, M Ishida, S Martins, WD Johnson, ... The Lancet Public Health 7 (1), e74-e85, 2022 | 253 | 2022 |
| Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial L Manning, Y Hirakawa, H Arima, X Wang, J Chalmers, J Wang, R Lindley, ... The Lancet Neurology 13 (4), 364-373, 2014 | 253 | 2014 |
| Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint … CS Anderson, Y Huang, RI Lindley, X Chen, H Arima, G Chen, Q Li, ... The Lancet 393 (10174), 877-888, 2019 | 226 | 2019 |
Craig AndersonProfessor of Neurology and Epidemiology, The University of NSWVerified email at georgeinstitute.org.au
